Navigation Links
Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
Date:7/30/2012

ormula subject to certain limitations.  CTI may instead elect to pay all or some of such value in cash.  If CTI elects not to pay in cash, is unable to issue sufficient shares without shareholder approval and has not obtained shareholder approval within 90 days after an exchange notice is received, CTI will issue a note for the unpaid portion of the value payable one year thereafter.

CTI paid Halcyon Cabot Partners, Ltd. a placement agent fee of 5% of the gross proceeds received in the Second Closing.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of CTI's securities. Risks that contribute to the uncertain nature of the forward-looking statements include, among others, risks associated with market conditions, that CTI may not use the net proceeds of the Second Closing as expected, as well as risks related to developments in the biopharmaceutical industry, the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, costs of developing, producing and selling CTI's drug candidates, that CTI may not be able to successfully implement its plans, strategies and objectives related to the development of the acquired compounds, the risk that CTI may not be able to sustain its current cost controls, and the risk that CTI may not be able to continue to raise capital as needed to fund its ope
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... -- Within just two years after reaching a milestone ... 3,000 employees worldwide. This increase is reflecting a ... delivery market and SHL,s effective commitment, productivity and ... design and manufacturing of auto injectors and pen ... a lean supply chain, strong partnerships, and more. ...
(Date:9/1/2015)... , Aug. 31, 2015 Research ... addition of the "Introduction to Veterinary Pharmacovigilance ... their offering. This course has ... good introduction to those concerned with Veterinary Pharmacovigilance. ... personnel who reqire a better understanding of veterinay ...
(Date:9/1/2015)... 2015 - The ... egistry data presented at ESC Congress ... the evolution of manag ing AF in ... -   The first-ever two-year outcomes from the Global Anticoagulant ... expose that all-cause death was the most frequent major event in more than ...
Breaking Medicine Technology:SHL Group Reaches Major Milestone of 3000 Employees 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
... 2012  Before purchasing electronic health records software ... management features, supported architectures and the ONC-ATCB certification ... consists of health information compiled from multiple health-oriented ... contains a patient,s medical information from one organization, ...
... Inc. (NYSE: PRX ) announced today that it will ... 2012 at 9:00 AM EST to review results for the fourth ... results on February 28, 2012 before the market opens. ... website at www.parpharm.com . Dial-in Information ...
Cached Medicine Technology:Let FindTheBest Help You Choose The Best Electronic Health Record Software 2
(Date:9/1/2015)... ... September 01, 2015 , ... As part ... and Blue Shield of Minnesota (Blue Cross) has announced Doctor On Demand as ... San Francisco, Doctor On Demand provides immediate access to Board Certified physicians or ...
(Date:9/1/2015)... ... 2015 , ... Virginia entrepreneur Marcella Ellis, CEO and founder ... firm’s success in the hair care and distribution industry through her combination of ... be providing “Look and learn” live demonstrations, as well as promoting her new ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... has announced that Edge Information Management has been granted continued accreditation ... Credentialing Council (BSCC). , “Achieving and maintaining this accreditation takes the ...
(Date:9/1/2015)... ... ... With former IBMers among its founding members, Inmar has known the value of ... ago. A pilot program begun by the company in 2014 has proved popular with ... pursuing careers in these fields. The program is now open to area middle and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Royal River Natural Foods, a locally-owned independent natural ... women for 19 years and found that, among those who had a stroke, people ... report is part of the September 2015 issue of “Natural Insights for Well Being,” ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... Provides Important Tool to Fight Pandemic , , ... that it has approved four vaccines against the 2009 H1N1 influenza virus. ... which is expected within the next four weeks. , , ... , "Today,s approval is good news for our nation,s response ...
... have little effect on risk factor for heart disease, ... In people with newly diagnosed type 2 diabetes, the ... the inflammation associated with heart disease, new research suggests. ... the researchers found they didn,t affect inflammatory markers any ...
... Agency expects first batches to be available within a month ... and Drug Administration on Tuesday approved four new H1N1 swine ... within four weeks. , "Today,s approval is good news for ... Commissioner Dr. Margaret A. Hamburg said in a news release. ...
... , WASHINGTON, Sept. 15 ... progressives, a majority of liberals oppose extending taxpayer-funded healthcare to ... a universal plan and agree with the President,s handling of ... healthcare coverage to illegal aliens and result in increased costs. ...
... , NASHVILLE, Tenn., Sept. 15 ... named to the InformationWeek 500, which lists the nation,s most innovative ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO ) , ... September 14, 2009 at an awards ceremony held during the InformationWeek ...
... 15, 2009) A research project looking for ways to ... the bone health of cancer patients undergoing radiation treatment. ... of space causes bone loss in astronauts, but until recently, ... bones. Dr. Ted Bateman leads a project funded by the ...
Cached Medicine News:Health News:FDA Approves Vaccines for 2009 H1N1 Influenza Virus 2Health News:FDA Approves Vaccines for 2009 H1N1 Influenza Virus 3Health News:Diabetes Medications Don't Lower Inflammation 2Health News:Diabetes Medications Don't Lower Inflammation 3Health News:FDA Approves 4 Swine Flu Vaccines 2Health News:FDA Approves 4 Swine Flu Vaccines 3Health News:FDA Approves 4 Swine Flu Vaccines 4Health News:Poll: Liberals Oppose Healthcare for Illegal Aliens 2Health News:Hospital Corporation of America Recognized by InformationWeek as One of Nation's Most Innovative Users of Business Technology 2Health News:Space-related radiation research could help reduce fractures in cancer survivors 2Health News:Space-related radiation research could help reduce fractures in cancer survivors 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: